Stocks / Biotech

RVMDBiotech

Revolution Medicines, Inc.
$196.501d -3.9%5d -5.5%settled close · 2026-09-16
Mkt cap $19B (3/25)β 0.9552w $136–222Shares 198.2MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2020Emp. 883HQ Redwood City, CArevmed.com
Who’s talkingIdea Scout · free

Who’s talking about RVMD

No tracked investor commentary on RVMD yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 3 Nov 2026 after the close

Confirmed date · consensus EPS -2.48. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where RVMD’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 10 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-16
2026-09-11
2026-08-26
2026-08-21
2026-08-17
2026-06-29
2026-06-25
2026-06-09
2026-06-02
2026-06-01
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on RVMD is in this morning’s Brief. Get The Brief — $20/mo →